<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58589">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01755234</url>
  </required_header>
  <id_info>
    <org_study_id>STU00070833</org_study_id>
    <nct_id>NCT01755234</nct_id>
  </id_info>
  <brief_title>Propofol Versus Sevoflurane Recovery After Gynecological Surgery</brief_title>
  <official_title>The Effects of Propofol vs. Sevoflurane Administered During Anesthesia Maintenance on Early and Late Recovery After Gynecological Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      80% of 25 million American who undergo surgery describe moderate to severe pain. The use of
      multimodal analgesic techniques can attenuate patient's postoperative pain and several
      different medication have been found to be effective. Pain can significantly affect
      patient's quality of recovery after surgery. Volatile anesthetics can increase sensitivity
      to pain at the low concentrations present on emergence from anesthesia. Propofol may have
      analgesic effect at sedative doses. The effects of propofol,when used for  anesthesia
      maintenance, on postoperative pain have demonstrated controversial results with some
      investigators showing a potential benefit  whereas others have not shown any benefit.
      Propofol for maintenance of anesthesia has been advocated as an strategy for high risk
      patients even though it has shown controversial results on reduction of Post operative
      nausea and vomiting. A comparison of propofol vs.volatile anesthetic in regards to the time
      required by patients to meet discharge criteria has also shown conflicting results.The QOR
      40 is a validated instrument that has been specifically developed to evaluate patients
      recovery after anesthesia and surgery.

      The purpose of this study is to compare the effects of maintenance of anesthesia with two
      agents (Propofol and Sevoflurane) on quality of recovery after ambulatory surgery

      Significance: the results of this study can lead to the discovery of an anesthesia technique
      that is associated with a better recovery for patients after ambulatory surgery.

      Research question is: do patients anesthetized with propofol have a better quality of
      recovery after ambulatory anesthesia than patients anesthetized with Sevoflurane? The
      hypothesis: patients anesthetized with propofol will have better quality of recovery than
      patients anesthetized with Sevoflurane after ambulatory surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Quality of recovery score 24 hours post operative</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of recovery score 24 hours post operative</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Surgery</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sevoflurane administered by inhalation (laryngeal mask airway or endotracheal tube)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol administered via intravenous catheter at an initial  rate of 1.0 -2.0 mg/kg  then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Sevfoflurane inhaled administered by laryngeal mask airway or endotracheal tube</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <other_name>Sevoflurane,Ultane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol administered via intravenous catheter at an initial  rate of 1.0 -2.0 mg/kg  then the Propofol infusion rate will be titrated to keep a bispectral index between 40-60</description>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>Propofol,Diprivan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women

          -  Age 18-64

          -  Patients undergoing ambulatory surgery

          -  ASA PS I, II

        Exclusion Criteria:

          -  Chronic opioid use

          -  Pregnant patient

        Drop Out : patient or surgeon request
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gildasio De Oliveira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gildasio De Oliveira, MD</last_name>
    <phone>(312)472-3585</phone>
    <email>gjr@northwestern.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Prentice Womens Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gildasio De Oliveira, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gildasio De Oliveira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>White PF, Kehlet H. Improving postoperative pain management: what are the unresolved issues? Anesthesiology. 2010 Jan;112(1):220-5. doi: 10.1097/ALN.0b013e3181c6316e. Review.</citation>
    <PMID>20010418</PMID>
  </reference>
  <reference>
    <citation>White PF. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth Analg. 2005 Nov;101(5 Suppl):S5-22. Review.</citation>
    <PMID>16334489</PMID>
  </reference>
  <reference>
    <citation>Zhang Y, Eger EI 2nd, Dutton RC, Sonner JM. Inhaled anesthetics have hyperalgesic effects at 0.1 minimum alveolar anesthetic concentration. Anesth Analg. 2000 Aug;91(2):462-6.</citation>
    <PMID>10910869</PMID>
  </reference>
  <reference>
    <citation>Hand R Jr, Riley GP, Nick ML, Shott S, Faut-Callahan M. The analgesic effects of subhypnotic doses of propofol in human volunteers with experimentally induced tourniquet pain. AANA J. 2001 Dec;69(6):466-70.</citation>
    <PMID>11837149</PMID>
  </reference>
  <reference>
    <citation>Cheng SS, Yeh J, Flood P. Anesthesia matters: patients anesthetized with propofol have less postoperative pain than those anesthetized with isoflurane. Anesth Analg. 2008 Jan;106(1):264-9, table of contents. doi: 10.1213/01.ane.0000287653.77372.d9.</citation>
    <PMID>18165589</PMID>
  </reference>
  <reference>
    <citation>Boccara G, Mann C, Pouzeratte Y, Bellavoir A, Rouvier A, Colson P. Improved postoperative analgesia with isoflurane than with propofol anaesthesia. Can J Anaesth. 1998 Sep;45(9):839-42.</citation>
    <PMID>9818105</PMID>
  </reference>
  <reference>
    <citation>Visser K, Hassink EA, Bonsel GJ, Moen J, Kalkman CJ. Randomized controlled trial of total intravenous anesthesia with propofol versus inhalation anesthesia with isoflurane-nitrous oxide: postoperative nausea with vomiting and economic analysis. Anesthesiology. 2001 Sep;95(3):616-26.</citation>
    <PMID>11575532</PMID>
  </reference>
  <reference>
    <citation>Watson KR, Shah MV. Clinical comparison of 'single agent' anaesthesia with sevoflurane versus target controlled infusion of propofol. Br J Anaesth. 2000 Oct;85(4):541-6.</citation>
    <PMID>11064611</PMID>
  </reference>
  <reference>
    <citation>Röhm KD, Piper SN, Suttner S, Schuler S, Boldt J. Early recovery, cognitive function and costs of a desflurane inhalational vs. a total intravenous anaesthesia regimen in long-term surgery. Acta Anaesthesiol Scand. 2006 Jan;50(1):14-8. Retraction in: Acta Anaesthesiol Scand. 2011 Aug;55(7):903.</citation>
    <PMID>16451145</PMID>
  </reference>
  <reference>
    <citation>Montes FR, Trillos JE, Rincón IE, Giraldo JC, Rincón JD, Vanegas MV, Charris H. Comparison of total intravenous anesthesia and sevoflurane-fentanyl anesthesia for outpatient otorhinolaryngeal surgery. J Clin Anesth. 2002 Aug;14(5):324-8.</citation>
    <PMID>12208434</PMID>
  </reference>
  <reference>
    <citation>Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000 Jan;84(1):11-5.</citation>
    <PMID>10740540</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 7, 2014</lastchanged_date>
  <firstreceived_date>December 18, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Gildasio De Oliveira</investigator_full_name>
    <investigator_title>Prinipal Investigator</investigator_title>
  </responsible_party>
  <keyword>Outpatient</keyword>
  <keyword>Surgery</keyword>
  <keyword>Anesthesia</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
